Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours

1. Chen, X.
2. Isambert, N.
3. López-López, R.
4. Giovannini, M.
5. Pognan, N.
6. Kapoor, S.
7. Quinlan, M.
8. You, B.
9. Cui, X.
10. Rahmanzadeh, G.
11. Mau-Sorensen, M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/BCP.15544 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus